Mycobacterial and nonbacterial pulmonary complications in hospitalized patients with human immunodeficiency virus infection: a prospective, cohort study
- PMID: 11602023
- PMCID: PMC57813
- DOI: 10.1186/1471-2466-1-1
Mycobacterial and nonbacterial pulmonary complications in hospitalized patients with human immunodeficiency virus infection: a prospective, cohort study
Abstract
Background: A prospective observational study was done to describe nonbacterial pulmonary complications in hospitalized patients with human immunodeficiency virus (HIV) infection.
Methods: The study included 1,225 consecutive hospital admissions of 599 HIV-infected patients treated from April 1995 through March 1998. Data included demographics, risk factors for HIV infection, Acute Physiology and Chronic Health Evaluation (APACHE) II score, pulmonary complications, CD4+ lymphocyte count, hospital stay and case-fatality rate.
Results: Patient age (mean +/- SD) was 38.2 +/- 8.9 years, 62% were men, and 84% were African American. The median APACHE II score was 14, and median CD4+ lymphocyte count was 60/microL. Pulmonary complications were Pneumocystis carinii pneumonia (85) in 78 patients, Mycobacterium avium complex (51) in 38, Mycobacterium tuberculosis (40) in 35, Mycobacterium gordonae (11) in 11, Mycobacterium kansasii (10) in 9, Cytomegalovirus (10) in 10, Nocardia asteroides (3) in 3, fungus ball (2) in 2, respiratory syncytial virus (1), herpes simplex virus (1), Histoplasma capsulatum (1), lymphoma (3) in 3, bronchogenic carcinoma (2) in 2, and Kaposi sarcoma (1). The case-fatality rate of patients was 11% with Pneumocystis carinii pneumonia; 5%, Mycobacterium tuberculosis; 6%, Mycobacterium avium complex; and 7%, noninfectious pulmonary complications.
Conclusion: Most pulmonary complications in hospitalized patients with HIV are from Pneumocystis and mycobacterial infection.
Similar articles
-
Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study.Chest. 2000 Apr;117(4):1017-22. doi: 10.1378/chest.117.4.1017. Chest. 2000. PMID: 10767233
-
Natural history of opportunistic disease in an HIV-infected urban clinical cohort.Ann Intern Med. 1996 Apr 1;124(7):633-42. doi: 10.7326/0003-4819-124-7-199604010-00003. Ann Intern Med. 1996. PMID: 8607591
-
Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU. The PIP (Pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study.Chest. 2000 Jul;118(1):138-45. doi: 10.1378/chest.118.1.138. Chest. 2000. PMID: 10893371
-
Cavitary pulmonary lesions in patients infected with human immunodeficiency virus.Clin Infect Dis. 1996 Apr;22(4):671-82. doi: 10.1093/clinids/22.4.671. Clin Infect Dis. 1996. PMID: 8729207 Review.
-
Cardiac tamponade in patients with human immunodeficiency virus disease.Angiology. 2003 Jul-Aug;54(4):469-74. doi: 10.1177/000331970305400411. Angiology. 2003. PMID: 12934767 Review.
Cited by
-
Etiology of Respiratory Complications among Iranian HIV Infected Patients.Tanaffos. 2019 Feb;18(2):96-103. Tanaffos. 2019. PMID: 32440296 Free PMC article.
-
Viral infections in inflammatory bowel disease: Tips and tricks for correct management.World J Gastroenterol. 2021 Jul 21;27(27):4276-4297. doi: 10.3748/wjg.v27.i27.4276. World J Gastroenterol. 2021. PMID: 34366605 Free PMC article. Review.
-
Respiratory Complications in Iranian Hospitalized Patients with HIV/AIDS.Tanaffos. 2011;10(3):49-54. Tanaffos. 2011. PMID: 25191376 Free PMC article.
-
Biodiversity of amoebae and amoeba-resisting bacteria in a hospital water network.Appl Environ Microbiol. 2006 Apr;72(4):2428-38. doi: 10.1128/AEM.72.4.2428-2438.2006. Appl Environ Microbiol. 2006. PMID: 16597941 Free PMC article.
-
Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease.BMC Pulm Med. 2009 May 18;9:22. doi: 10.1186/1471-2466-9-22. BMC Pulm Med. 2009. PMID: 19450259 Free PMC article.
References
-
- Murray JF, Felton CP, Garay SM, Gottlieb MS, Hopewell PC, Stover DE, Teirstein AS. Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop. N Engl J Med. 1984;310:1682–1688. - PubMed
-
- Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med. 1996;124:633–642. - PubMed
-
- Wallace JM, Hansen NI, Lavange L, Glassroth J, Browdy BL, Rosen MJ, Kvale PA, Mangura BT, Reichman LB, Hopewell PC. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med. 1997;155:72–80. - PubMed
-
- Stansell JD, Osmond DH, Charlebois E, LaVange L, Wallace JM, Alexander BV, Glossroth J, Kvale PA, Rosen MJ, Reichman LB, et al. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Am J Respir Crit Care Med. 1997;155:60–66. - PubMed
-
- Zaman MK, White DA. Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia. Diagnostic and prognostic significance. Am Rev Respir Dis. 1988;137:796–800. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous